...by the end of the week without a financial plan PR from the company.
The wise thing to do here is take your chips OFF THE TABLE until you hear otherwise. You'll be able to get back in soon enough if PR is released, in the meantime, you're losing money while Genta leadership scrambles to come up with millions more in non-dilutive financing just to keep the lights on, let alone run clinical trials.
My advice: Get out until you hear word on financing.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.